nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K1—epithelium—vulva cancer	0.224	0.224	CbGeAlD
Trametinib—MAP2K2—uterine cervix—vulva cancer	0.196	0.196	CbGeAlD
Trametinib—MAP2K2—urethra—vulva cancer	0.18	0.18	CbGeAlD
Trametinib—MAP2K2—mammalian vulva—vulva cancer	0.171	0.171	CbGeAlD
Trametinib—MAP2K1—lymph node—vulva cancer	0.0974	0.0974	CbGeAlD
Trametinib—MAP2K2—lymph node—vulva cancer	0.0858	0.0858	CbGeAlD
Trametinib—CYP2C8—vagina—vulva cancer	0.0459	0.0459	CbGeAlD
